Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: Donor type matters

Blood

Volumn 103, Issue 12, 2004, Pages 4674-4680

  El Zimaity, Maha ^a   Saliba, Rima ^a   Chan, Kawah ^a   Shahjahan, Munir ^a   Carrasco, Antonio ^a   Khorshid, Ola ^a   Caldera, Humberto ^a   Couriel, Daniel ^a   Giralt, Sergio ^a   Khouri, Issa ^a   Ippoliti, Cindy ^a   Champlin, Richard ^a   De Lima, Marcos ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD DONOR; BLOOD GROUP TYPING; CHILD; DONOR; DRUG USE; FEMALE; GRAFT VERSUS HOST REACTION; HEMORRHAGIC CYSTITIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MATCHED UNRELATED DONOR; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STEM CELL; UNRELATED CORD BLOOD; WHOLE BODY RADIATION;

EID: 2942619986     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-08-2815     Document Type: Article

References (44)

1. Seber A., Shu XO, Defor T, et al. Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplantation. 1999;23:35-40.
2. Vose JM, Reed EC, Rippert G, et al. Mesna compared with continuous bladder irrigation as uroprotection during high dose chemotherapy and transplantation: a randomized trial. J Clin Oncol. 1993;11:1306-1310.
3. Atkinson K, Biggs JC, Golovsky D, et al. Bladder irrigation does not prevent hemorrhagic cystitis in bone marrow transplant recipients. Bone Marrow Transplantation. 1991;7:351-354.
4. Seabra C, Pérez-Simón J, Sierra M, et al. Case report: intra-muscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogeneic stem cell transplantation. Bone Marrow Transplantation. 2000;26,11:1229-1230.
5. Miyamura K, Hamaguchi M, Taji H, et al. Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplantation. 2000;25:545-548.
6. Held T, Bie S, Nitsche A, et al. Case report: treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplantation. 2000;26:347-350.
7. Hattori K, Yabe M, Matsumoto M, et al. Case report: successful hyperbaric oxygen treatment of life-threatening hemorrhagic cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplantation. 2001;27:1315-1317.
8. Srivastava A, Nair S, Srivastava V, et al. Evaluation of uroprotective efficacy of amifostine against cyclophosphamide induced hemorrhagic cystitis. Bone Marrow Transplantation. 1999;23:463-467.
9. Demesmay K, Tissot E, Bulabois C, et al. Factor XIII replacement in stem-cell transplant recipients with severe hemorrhagic cystitis: a report of four cases. Transplantation. 2002;74:1190-1192.
10. Lakhani A, Raptis A, Frame D, et al. Case report: Intravesicular instillation of E-aminocaproic acid for patients with adenovirus-induced hemorrhagic cystitis. Bone Marrow Transplantation. 1999;24:1259-1260.
11. Tunuguntla H, Bhandari M, Srivastava A, et al. Endoscopic injection sclerotherapy control of intractable hematuria following radiation-induced hemorrhagic cystitis: A novel approach. Arch Esp Urol. 2000;53:396-402.
12. Koc S, Hagglund K, Ireton R, et al. Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 2000;26:899-901.
13. Machaczka M, Rucinska M, Piatkowska-Jakubas B, et al. Hemorrhagic cystitis caused high-dose conditioning chemotherapy before bone marrow transplantation. Przegel Lek. 2001;58:51-53.
14. Letendre L, Hoagland HC, Gertz MA. Hemorrhagic cystitis complicating bone marrow transplantation. Mayo Clin Proc. 1992;67:128-130.
15. Brugieres L, Hartman O, Travagli JP, et al. Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol. 1989;7:194-199.
16. Hale G, Heslop H, Krance R, et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplantation. 1999;23:277-282.
17. Garcia Ligero J, Mora Peris B, Garcia Garcia F, et al. Hemorrhagic cystitis caused by BK and JC polyomavirus in patients treated with bone marrow transplantation; clinical features and urological management. Acta Urol Esp. 2002;26:104-110.
18. Baronciani D, Angelucci E, Erer B, et al. Surapubic cystotomy as treatment for severe hemorrhagic cystitis after bone marrow transplantation. Bone Marrow Transplantation. 1995;16:267-270.
19. Vogeli TA, Peinemann F, Burdach S, et al. Urological treatment and clinical course of BK polyomavirus-associated hemorrhagic cystitis in children after bone marrow transplantation. Eur Urol. 1999;36:252-257.
20. Brugieres L, Hartmann O, Travalgi JP, et al. Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol. 1989;7:194-199.
21. Sencer SF, Haake RJ, Weisdorf DJ. Hemorrhagic cystitis after bone marrow transplantation: risk factor and complications. Transplantation. 1993;56:875-879.
22. Russell SJ, Vowels MR, Vale T. Hemorrhagic cystitis in pediatric bone marrow transplant patients: an association with infective agents, GVHD and prior cyclophosphamide. Bone Marrow Transplantation. 1994;13:533-539.
23. Link H, Neef V, Niethammer D, et al. Prophylaxis of hemorrhagic cystitis due to cyclophosphamide-conditioning for bone marrow transplantation. Blut. 1981;43:329-330.
24. Goddard AG, Saha V. Late onset hemorrhagic cystitis following bone marrow transplant: a case report. Pediatr Hematol Oncol. 1997;14:273-275.
25. Prentice RL, Kalbfleisch JD, Peterson AV Jr, Floumoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics. 1978;34:541-554.
26. Akiyama H, Kurosu T, Sakashita C, et al. Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis. 2001;32:1325-1330.
27. Carrigan D, Wisconsin M. Adenovirus infections in immunocompromised patients. Am J Med. 1997;102:71-74.
28. Ikegame K, Takimoto T, Takahashi R, et al. Lethal adenovirus infection in a patient who had undergone nonmyeloablative stem cell transplantation. Int J Hematol. 2001;74:95-100.
29. La Rosa A, Champlin R, Mirza N, et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis. 2001;32:871-876.
30. Childs R, Sanchez C, Engler H, et al. High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplantation. 1998;22:889-893.
31. Leung A, Suen C, Lie A, et al. Quantification of polyoma BK viruda in hemorrhagic cystitis complicating bone marrow transplantation. Blood. 2001;98:1971-1978.
32. Barouch D, Faquin W, Chen Y, et al. Virus-associated hemorrhagic cystitis in a human immunodeficiency virus-infected patient. Clin Infect Dis. 2002;35:326-329.
33. Nevo S, Swan V, Enger C, et al. Acute bleeding after bone marrow transplantation (BMT)-incidence and effect on survival: a quantitative analysis in 1,402 patients. Blood. 1998;91:1469-1477.
34. Öst L, Lönnovist B, Eriksson L, et al. Hemorrhagic cystitis - a manifestation of graft versus host disease? Bone Marrow Transplantation. 1987;2:19-25.
35. Echavarria M, Herrera F, Solimano J, et al. Cyclic recovery of adenovirus in a stem cell transplant recipient: an inverse association with graft-versus-host disease. Bone Marrow Transplantation. 2003;31:301-303.
36. Ruutu T, Volin L, Leskinen R. Severe cystitis as a manifestation of chronic graft-versus-host disease after bone marrow transplantation Br J Urol. 1988;62:612-613.
37. Trotman J, Nivison-Smith I, Dodds A. Hemorrhagic cystitis incidence and risk factors in a transplant population using hyperhydration. Bone Marrow Transplantation. 1999;23:797-801.
38. Bedi A, Miller C, Hanson J, et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol. 1995;13:1103-1109.
39. Aleksa K, Woodland C, Koren G. Young age and the risk for ifosfamide-induced nephrotoxicity: a critical review of two opposing studies. Pediatr Nephrol. 2001;16:1153-1158.
40. Skinner R, Cotterill SJ, Stevens MC. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCGS Late Effects Group study. United Kingdom Children's Cancer Study Group. Br J Cancer. 2000;82:1636-1645.
41. Loebstein R, Atanackovic G, Bishai R, et al. Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children. J Clin Pharmacol. 1999;39:454-461.
42. Kondo M, Kojima K, Matsuyama T. Late-onset hemorrhagic cystitis after stem cell transplantation in children. Bone Marrow Transplantation. 1998;22:995-998.
43. Dei R, Marmo F, Corte D, et al. Age-related changes in the prevalence of precipitating antibodies to BK virus in infants and children. J Med Microbiol. 1982;15:285-291.
44. Bogdanovic G, Ljungman P, Wang F, et al. Presence of human polyomavirus DNA in the peripheral circulation of bone marrow transplant patients with and without hemorrhagic cystitis. Bone Marrow Transplantation. 1996;17:573-576.